跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Solbriz - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Solbriz
Approved
STANDARD
Solbriz
Lloyd Laboratories, Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
b5d876c91ad057b1
Company
Lloyd Laboratories, Inc.
Type
Standard
Approval Details
Approval Id
b5d876c91ad057b1
Drug Approval Philippines Name
Solbriz
Product Name
Solbriz
Registration Number
DR-XY48431
Brand Name
Solbriz
Generic Name
Acetylcysteine
Dosage Form
Powder for Oral Solution
Dosage Strength
200 mg
Manufacturer
Lloyd Laboratories, Inc.
Trader
Solvang Pharmaceuticals, Inc.
Issuance Date
26 October 2022
Expiry Date
26 October 2027
Pharmacologic Category
Mucolytic
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
b5d876c91ad057b1
Type
Standard
Back to Philippines FDA Approvals